Founder & CTO
MIT-trained computational biologist who returned to Australia and joined the research team at Garvan Institute in Darlinghurst. Her work on protein folding prediction led to a startup focused on accelerating drug discovery timelines for rare diseases. Collaborates closely with academic labs across Sydney's biotech corridor.